| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
IDXX Stock Overview
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.
IDEXX Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$428.54 |
| 52 Week High | US$664.70 |
| 52 Week Low | US$317.06 |
| Beta | 1.18 |
| 1 Month Change | 11.92% |
| 3 Month Change | 14.54% |
| 1 Year Change | -29.47% |
| 3 Year Change | 70.14% |
| 5 Year Change | 176.03% |
| Change since IPO | 45,233.18% |
Recent News & Updates
Recent updates
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Nov 24
When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Sep 20These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
Aug 15Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?
Jul 26Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today
Jul 12Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jun 16We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
May 06Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?
Apr 23With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting
Apr 09Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Mar 07Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?
Jan 06These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Safely
Oct 17With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting
Oct 04Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Potentially Undervalued?
Sep 08IDEXX Laboratories (NASDAQ:IDXX) Looks To Prolong Its Impressive Returns
Aug 11These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Safely
Jul 10At US$561, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?
Jun 09Do IDEXX Laboratories's (NASDAQ:IDXX) Earnings Warrant Your Attention?
May 27Many Would Be Envious Of IDEXX Laboratories' (NASDAQ:IDXX) Excellent Returns On Capital
May 05Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Apr 05Are Institutions Heavily Invested In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shares?
Mar 21Is Now An Opportune Moment To Examine IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Mar 08Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Feb 23M. Szostak Is The Independent Director of IDEXX Laboratories, Inc. (NASDAQ:IDXX) And They Just Sold 54% Of Their Shares
Feb 10A Look Into IDEXX Laboratories' (NASDAQ:IDXX) Impressive Returns On Capital
Jan 31
Shareholder Returns
| IDXX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -2.4% | -1.1% | -2.8% |
| 1Y | -29.5% | -20.9% | -19.6% |
Return vs Industry: IDXX underperformed the US Medical Equipment industry which returned -20.9% over the past year.
Return vs Market: IDXX underperformed the US Market which returned -19.6% over the past year.
Price Volatility
| IDXX volatility | |
|---|---|
| IDXX Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 8.9% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: IDXX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: IDXX's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 10,350 | Jay Mazelsky | https://www.idexx.com |
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.
IDEXX Laboratories, Inc. Fundamentals Summary
| IDXX fundamental statistics | |
|---|---|
| Market Cap | US$35.49b |
| Earnings (TTM) | US$669.65m |
| Revenue (TTM) | US$3.34b |
53.0x
P/E Ratio10.6x
P/S RatioIs IDXX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDXX income statement (TTM) | |
|---|---|
| Revenue | US$3.34b |
| Cost of Revenue | US$1.36b |
| Gross Profit | US$1.98b |
| Other Expenses | US$1.31b |
| Earnings | US$669.65m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 06, 2023
| Earnings per share (EPS) | 8.09 |
| Gross Margin | 59.16% |
| Net Profit Margin | 20.05% |
| Debt/Equity Ratio | 292.8% |
How did IDXX perform over the long term?
See historical performance and comparison